Has Merck Found The Heir To Fosamax?

Merck's new bone drug appears to work, according to a clinical trial of the osteoporosis treatment that was stopped early tonight, although investors will have to wait to see full results of the study. Full results won't be available for some time. But the news that an independent data safety and [...]